Advances in Anti Rheumatic Therapy
This work on advances in anti-rheumatic therapy covers topics such as: outcome measures in clinical trials of anti-rheumatic drugs; azapropazone (AZP); the mode of action of glucocorticoids; and clinical trials of oral chondroitin sulphate in the treatment of osteoarthritis.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Selective Monoclonal Antibodies for Therapy of Rheumatic Diseases
action activity administration agents analgesic anti-rheumatic drugs antibody antigen arachidonic Arthritis Rheum aspirin assessment auranofin autoimmune azapropazone Biochem cancer cartilage cells chronic Clin clinical trials combination tablet compared corticosteroids cytokines diclofenac DMARD dose double-blind efficacy enzyme etodolac evaluation exposure factors follow-up function gastric gastrointestinal glucocorticoids hepatic human ibuprofen Immunol incidence increase indomethacin induced inflammation inflammatory inhibition inhibitors interaction joint ketorolac leukocytes leukotriene long-term lymphocytes macrophages measures meloxicam metabolism metabolites misoprostol mucosal nabumetone naproxen neutrophil nimesulide non-steroidal anti-inflammatory drugs NSAIDs oral osteoarthritis oxaprozin pain patients with rheumatoid pharmacokinetics Pharmacol Pharmacology piroxicam placebo plasma concentration potential production prostaglandin protein psychological RA patients RAAR Rainsford rats reactions receptor reduced renal response rheumatic diseases rheumatoid arthritis Rheumatol risk salicylate side effects significant steroids stimulated Subreum Suppl synovial synthesis tenidap therapeutic therapy tissue toxicity treatment ulcer vascular vitro vivo zileuton